These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6146677)

  • 1. Monoamine oxidase inhibition by the tremorogenic drug--LON 954.
    Mitra C; Ganguly DK; Guha SR
    J Pharm Pharmacol; 1984 Jun; 36(6):408-10. PubMed ID: 6146677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride (LON-954) a new tremorogenic agent.
    Coward DM; Doggett NS; Sayers AC
    Arzneimittelforschung; 1977; 27(12):2326-32. PubMed ID: 580044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-carbamoyl-2-(2,6-dichlorophenyl) acetamidine hydrochloride (LON-954), a tremorogen, on rat diaphragm.
    Vedasiromoni JR; Ganguly DK
    Jpn J Pharmacol; 1984 Mar; 34(3):353-5. PubMed ID: 6727073
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha 2-antagonistic effect of N-carbamoyl-2-(2,6-dichlorophenyl) acetamidine hydrochloride (LON-954).
    Das M; Chauhan SP; Ganguly DK
    Eur J Pharmacol; 1988 Apr; 149(1-2):55-60. PubMed ID: 2899516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK; Molloy BB
    Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tremorogenesis by LON-954 [N-carbamoyl-2-(2,6-dichlorophenyl) acetamidine hydrochloride]: evidence for the involvement of 5-hydroxytryptamine.
    Mohanakumar KP; Ganguly DK
    Brain Res Bull; 1989 Feb; 22(2):191-5. PubMed ID: 2706533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
    Green AL; McGachy HA
    J Pharm Pharmacol; 1987 May; 39(5):392-4. PubMed ID: 2886590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amethocaine-induced inhibition of mitochondrial monoamine oxidase activity.
    Haque SJ; Poddar MK
    J Pharm Pharmacol; 1986 Nov; 38(11):858-60. PubMed ID: 2879023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibition by novel antidepressant tetrindole.
    Medvedev AE; Kirkel AA; Kamyshanskaya NS; Moskvitina TA; Axenova LN; Gorkin VZ; Andreeva NI; Golovina SM; Mashkovsky MD
    Biochem Pharmacol; 1994 Jan; 47(2):303-8. PubMed ID: 8304974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of beta-phenylethylamine by both types of monoamine oxidase: examination of enzymes in brain and liver mitochondria of eight species.
    Suzuki O; Katsumata Y; Oya M
    J Neurochem; 1981 Mar; 36(3):1298-301. PubMed ID: 7205271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
    O'Brien EM; Dostert P; Tipton KF
    Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase activity by phenacetin and salicylamide.
    Byczkowski JZ; Korolkiewicz KZ
    Pharmacol Res Commun; 1976 Oct; 8(5):477-83. PubMed ID: 1026969
    [No Abstract]   [Full Text] [Related]  

  • 17. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential inhibition of the B-form of monoamine oxidase in the liver of rats given 3'-methyl-4-dimethylaminoazobenzene in the diet.
    Egashira T; Yamamoto T; Yamanaka Y; Kuroiwa Y
    Biochem Pharmacol; 1982 Apr; 31(7):1301-7. PubMed ID: 6807318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.